Announcement • Jun 26
C.E.Management Integrated Laboratory Co.Ltd to Report Q2, 2026 Results on Aug 07, 2026 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q2, 2026 results on Aug 07, 2026 Upcoming Dividend • Jun 22
Upcoming dividend of JP¥6.00 per share Eligible shareholders must have bought the stock before 29 June 2026. Payment date: 02 September 2026. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Japanese dividend payers (3.9%). Higher than average of industry peers (1.1%). Reported Earnings • May 20
First quarter 2026 earnings released: EPS: JP¥13.36 (vs JP¥7.47 in 1Q 2025) First quarter 2026 results: EPS: JP¥13.36 (up from JP¥7.47 in 1Q 2025). Revenue: JP¥2.14b (up 18% from 1Q 2025). Net income: JP¥190.0m (up 79% from 1Q 2025). Profit margin: 8.9% (up from 5.9% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Announcement • May 10
C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2026 Results on May 15, 2026 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q1, 2026 results on May 15, 2026 Declared Dividend • Apr 11
Final dividend of JP¥6.00 announced Dividend of JP¥6.00 is the same as last year. Ex-date: 29th June 2026 Payment date: 2nd September 2026 Dividend yield will be 3.0%, which is higher than the industry average of 1.2%. Sustainability & Growth Dividend is covered by both earnings (35% earnings payout ratio) and cash flows (66% cash payout ratio). The dividend has increased by an average of 10% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Mar 28
Full year 2025 earnings released: EPS: JP¥33.90 (vs JP¥25.47 in FY 2024) Full year 2025 results: EPS: JP¥33.90 (up from JP¥25.47 in FY 2024). Revenue: JP¥7.70b (up 4.8% from FY 2024). Net income: JP¥482.0m (up 33% from FY 2024). Profit margin: 6.3% (up from 4.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 8% per year. Reported Earnings • Feb 16
Full year 2025 earnings released: EPS: JP¥33.90 (vs JP¥25.47 in FY 2024) Full year 2025 results: EPS: JP¥33.90 (up from JP¥25.47 in FY 2024). Revenue: JP¥7.70b (up 4.8% from FY 2024). Net income: JP¥482.0m (up 33% from FY 2024). Profit margin: 6.3% (up from 4.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 13% per year. Announcement • Feb 13
C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2026 C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2026. New Risk • Jan 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Market cap is less than US$100m (JP¥7.01b market cap, or US$44.2m). Upcoming Dividend • Dec 22
Upcoming dividend of JP¥6.00 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 24 March 2026. Payout ratio is a comfortable 46% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.1%). Announcement • Dec 17
C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2025 Results on Feb 10, 2026 C.E.Management Integrated Laboratory Co.Ltd announced that they will report fiscal year 2025 results on Feb 10, 2026 Reported Earnings • Nov 14
Third quarter 2025 earnings released: EPS: JP¥3.09 (vs JP¥2.13 in 3Q 2024) Third quarter 2025 results: EPS: JP¥3.09 (up from JP¥2.13 in 3Q 2024). Revenue: JP¥1.83b (up 5.9% from 3Q 2024). Net income: JP¥44.0m (up 45% from 3Q 2024). Profit margin: 2.4% (up from 1.8% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth. Buy Or Sell Opportunity • Oct 28
Now 20% undervalued Over the last 90 days, the stock has risen 5.1% to JP¥456. The fair value is estimated to be JP¥570, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 8.9%. Buy Or Sell Opportunity • Oct 10
Now 21% undervalued Over the last 90 days, the stock has risen 21% to JP¥447. The fair value is estimated to be JP¥567, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 8.9%. Announcement • Sep 27
C.E.Management Integrated Laboratory Co.Ltd to Report Q3, 2025 Results on Nov 11, 2025 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q3, 2025 results on Nov 11, 2025 Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to JP¥523, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 17x in the Professional Services industry in Japan. Total returns to shareholders of 85% over the past three years. Declared Dividend • Sep 03
First half dividend of JP¥6.00 announced Dividend of JP¥6.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 24th March 2026 Dividend yield will be 2.6%, which is higher than the industry average of 1.2%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (65% cash payout ratio). The dividend has increased by an average of 10% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 3.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 08
Second quarter 2025 earnings released: EPS: JP¥2.17 (vs JP¥3.38 in 2Q 2024) Second quarter 2025 results: EPS: JP¥2.17 (down from JP¥3.38 in 2Q 2024). Revenue: JP¥1.76b (up 4.7% from 2Q 2024). Net income: JP¥30.8m (down 36% from 2Q 2024). Profit margin: 1.8% (down from 2.9% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to JP¥470, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 16x in the Professional Services industry in Japan. Total returns to shareholders of 61% over the past three years. Upcoming Dividend • Jun 20
Upcoming dividend of JP¥6.00 per share Eligible shareholders must have bought the stock before 27 June 2025. Payment date: 03 September 2025. Payout ratio is a comfortable 46% and this is well supported by cash flows. Trailing yield: 3.4%. Lower than top quartile of Japanese dividend payers (4.0%). Higher than average of industry peers (1.2%). Announcement • Jun 07
C.E.Management Integrated Laboratory Co.Ltd to Report Q2, 2025 Results on Aug 12, 2025 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q2, 2025 results on Aug 12, 2025 Reported Earnings • May 11
First quarter 2025 earnings released: EPS: JP¥7.45 (vs JP¥6.69 in 1Q 2024) First quarter 2025 results: EPS: JP¥7.45 (up from JP¥6.69 in 1Q 2024). Revenue: JP¥1.81b (down 2.8% from 1Q 2024). Net income: JP¥106.0m (up 12% from 1Q 2024). Profit margin: 5.9% (up from 5.1% in 1Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 3% per year. Declared Dividend • Apr 11
Final dividend of JP¥6.00 announced Dividend of JP¥6.00 is the same as last year. Ex-date: 27th June 2025 Payment date: 3rd September 2025 Dividend yield will be 3.5%, which is higher than the industry average of 1.2%. Sustainability & Growth Dividend is well covered by both earnings (47% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 12% per year over the past 9 years and payments have been stable during that time. Earnings per share has grown by 3.8% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to JP¥304, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 14x in the Professional Services industry in Japan. Total returns to shareholders of 1.1% over the past three years. Buy Or Sell Opportunity • Apr 07
Now 24% undervalued Over the last 90 days, the stock has risen 1.3% to JP¥306. The fair value is estimated to be JP¥404, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.5%. Announcement • Mar 29
C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2025 Results on May 09, 2025 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q1, 2025 results on May 09, 2025 Reported Earnings • Mar 27
Full year 2024 earnings released: EPS: JP¥25.47 (vs JP¥13.38 in FY 2023) Full year 2024 results: EPS: JP¥25.47 (up from JP¥13.38 in FY 2023). Revenue: JP¥7.35b (flat on FY 2023). Net income: JP¥362.0m (up 91% from FY 2023). Profit margin: 4.9% (up from 2.6% in FY 2023). Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 4% per year. New Risk • Feb 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.0% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Market cap is less than US$100m (JP¥6.40b market cap, or US$42.6m). Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improves as stock rises 39% After last week's 39% share price gain to JP¥450, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 15x in the Professional Services industry in Japan. Total returns to shareholders of 58% over the past three years. Reported Earnings • Feb 15
Full year 2024 earnings released: EPS: JP¥25.47 (vs JP¥13.38 in FY 2023) Full year 2024 results: EPS: JP¥25.47 (up from JP¥13.38 in FY 2023). Revenue: JP¥7.35b (flat on FY 2023). Net income: JP¥362.0m (up 91% from FY 2023). Profit margin: 4.9% (up from 2.6% in FY 2023). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Announcement • Feb 13
C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 21, 2025 C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 21, 2025. Announcement • Jan 03
C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2024 Results on Feb 13, 2025 C.E.Management Integrated Laboratory Co.Ltd announced that they will report fiscal year 2024 results at 12:00 PM, Tokyo Standard Time on Feb 13, 2025 Upcoming Dividend • Dec 20
Upcoming dividend of JP¥6.00 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 25 March 2025. Payout ratio is a comfortable 72% and this is well supported by cash flows. Trailing yield: 3.9%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (0.9%). Reported Earnings • Nov 11
Third quarter 2024 earnings released: EPS: JP¥2.11 (vs JP¥1.90 loss in 3Q 2023) Third quarter 2024 results: EPS: JP¥2.11 (up from JP¥1.90 loss in 3Q 2023). Revenue: JP¥1.72b (up 5.6% from 3Q 2023). Net income: JP¥30.0m (up JP¥57.0m from 3Q 2023). Profit margin: 1.7% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 4% per year. Announcement • Sep 27
C.E.Management Integrated Laboratory Co.Ltd to Report Q3, 2024 Results on Nov 13, 2024 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q3, 2024 results on Nov 13, 2024 Announcement • Aug 27
C.E.Management Integrated Laboratory Co.Ltd Announces Dividend for the Second Quarter End and Provides Fiscal year Ending December 31, 2024 C.E.Management Integrated Laboratory Co.Ltd announced dividend for the second quarter end and provides fiscal year ending December 31, 2024. For the second year end, the company announces dividend of JPY 6.00 per share
For the fiscal year end, the company expects dividend of JPY 6.00 per share. Announcement • Aug 26
C.E. Management Integrated Laboratory Co. Ltd Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2024 C.E.Management Integrated Laboratory Co.Ltd provided consolidated earnings guidance for the full year ending December 31, 2024. For the full year, the company expects net sales of JPY 7,661 million, operating profit of JPY 648 million, profit attributable to owners of parent of JPY 395 million and earnings per share of JPY 27.82. Reported Earnings • Aug 13
Second quarter 2024 earnings released: EPS: JP¥3.38 (vs JP¥3.59 in 2Q 2023) Second quarter 2024 results: EPS: JP¥3.38 (down from JP¥3.59 in 2Q 2023). Revenue: JP¥1.68b (down 6.8% from 2Q 2023). Net income: JP¥48.0m (down 5.9% from 2Q 2023). Profit margin: 2.9% (up from 2.8% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 6% per year. Declared Dividend • Aug 10
Dividend of JP¥6.00 announced Shareholders will receive a dividend of JP¥6.00. Ex-date: 27th December 2024 Payment date: 25th March 2025 Dividend yield will be 4.0%, which is higher than the industry average of 1.2%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is well covered by cash flows (19% cash payout ratio). The dividend has increased by an average of 12% per year over the past 9 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 2.9% to bring the payout ratio under control. However, EPS has declined by 11% over the last 5 years so the company would need to reverse this trend. Announcement • Jun 30
C.E.Management Integrated Laboratory Co.Ltd to Report Q2, 2024 Results on Aug 08, 2024 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q2, 2024 results on Aug 08, 2024 Reported Earnings • May 11
First quarter 2024 earnings released: EPS: JP¥6.69 (vs JP¥7.11 in 1Q 2023) First quarter 2024 results: EPS: JP¥6.69 (down from JP¥7.11 in 1Q 2023). Revenue: JP¥1.86b (down 1.5% from 1Q 2023). Net income: JP¥95.0m (down 5.9% from 1Q 2023). Profit margin: 5.1% (down from 5.3% in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Declared Dividend • Apr 11
Final dividend of JP¥6.00 announced Shareholders will receive a dividend of JP¥6.00. Ex-date: 27th June 2024 Payment date: 4th September 2024 Dividend yield will be 3.6%, which is higher than the industry average of 1.2%. Sustainability & Growth Dividend is covered by both earnings (89.7% earnings payout ratio) and cash flows (19% cash payout ratio). The dividend has increased by an average of 13% per year over the past 8 years and payments have been stable during that time. Earnings per share declined by 10% over the last 5 years, which if continued should see the payout ratio increase to a potentially unsustainable range. Announcement • Apr 03
C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2024 Results on May 09, 2024 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q1, 2024 results on May 09, 2024 Reported Earnings • Mar 28
Full year 2023 earnings released: EPS: JP¥13.38 (vs JP¥24.56 in FY 2022) Full year 2023 results: EPS: JP¥13.38 (down from JP¥24.56 in FY 2022). Revenue: JP¥7.33b (up 4.7% from FY 2022). Net income: JP¥190.0m (down 46% from FY 2022). Profit margin: 2.6% (down from 5.0% in FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 11
Full year 2023 earnings released: EPS: JP¥13.38 (vs JP¥24.56 in FY 2022) Full year 2023 results: EPS: JP¥13.38 (down from JP¥24.56 in FY 2022). Revenue: JP¥7.33b (up 4.7% from FY 2022). Net income: JP¥190.0m (down 46% from FY 2022). Profit margin: 2.6% (down from 5.0% in FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Announcement • Feb 11
C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 22, 2024 C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 22, 2024. Upcoming Dividend • Dec 21
Upcoming dividend of JP¥6.00 per share at 3.7% yield Eligible shareholders must have bought the stock before 28 December 2023. Payment date: 25 March 2024. Payout ratio is a comfortable 46% and this is well supported by cash flows. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (1.2%). Announcement • Dec 05
C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2023 Results on Feb 09, 2024 C.E.Management Integrated Laboratory Co.Ltd announced that they will report fiscal year 2023 results on Feb 09, 2024 Announcement • Nov 15
C.E.Management Integrated Laboratory Co.Ltd Provides Dividend Guidance for the Year Ending December 31, 2023 C.E.Management Integrated Laboratory Co.Ltd provided dividend guidance for the year ending December 31, 2023. For the year, the company expects to pay dividend of JPY 6.00 per share. Reported Earnings • Nov 11
Third quarter 2023 earnings released: JP¥1.90 loss per share (vs JP¥1.62 loss in 3Q 2022) Third quarter 2023 results: JP¥1.90 loss per share (further deteriorated from JP¥1.62 loss in 3Q 2022). Revenue: JP¥1.63b (up 1.0% from 3Q 2022). Net loss: JP¥27.0m (loss widened 17% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 11
Second quarter 2023 earnings released: EPS: JP¥3.59 (vs JP¥3.87 in 2Q 2022) Second quarter 2023 results: EPS: JP¥3.59 (down from JP¥3.87 in 2Q 2022). Revenue: JP¥1.80b (up 16% from 2Q 2022). Net income: JP¥51.0m (down 7.3% from 2Q 2022). Profit margin: 2.8% (down from 3.5% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Upcoming Dividend • Jun 22
Upcoming dividend of JP¥6.00 per share at 3.5% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 05 September 2023. Payout ratio is a comfortable 43% and this is well supported by cash flows. Trailing yield: 3.5%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (1.3%). Reported Earnings • May 14
First quarter 2023 earnings released: EPS: JP¥7.11 (vs JP¥6.19 in 1Q 2022) First quarter 2023 results: EPS: JP¥7.11 (up from JP¥6.19 in 1Q 2022). Revenue: JP¥1.89b (up 8.5% from 1Q 2022). Net income: JP¥101.0m (up 15% from 1Q 2022). Profit margin: 5.3% (up from 5.1% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year and the company’s share price has also increased by 1% per year. Reported Earnings • Mar 28
Full year 2022 earnings released: EPS: JP¥24.56 (vs JP¥14.86 in FY 2021) Full year 2022 results: EPS: JP¥24.56 (up from JP¥14.86 in FY 2021). Revenue: JP¥7.00b (down 4.7% from FY 2021). Net income: JP¥349.0m (up 64% from FY 2021). Profit margin: 5.0% (up from 2.9% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 1% per year. Reported Earnings • Feb 12
Full year 2022 earnings released: EPS: JP¥24.56 (vs JP¥14.86 in FY 2021) Full year 2022 results: EPS: JP¥24.56 (up from JP¥14.86 in FY 2021). Revenue: JP¥7.00b (down 4.7% from FY 2021). Net income: JP¥349.0m (up 64% from FY 2021). Profit margin: 5.0% (up from 2.9% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 11% per year. Announcement • Feb 12
C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2023 C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2023. Announcement • Jan 14
C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2022 Results on Feb 10, 2023 C.E.Management Integrated Laboratory Co.Ltd announced that they will report fiscal year 2022 results on Feb 10, 2023 Upcoming Dividend • Dec 22
Upcoming dividend of JP¥5.50 per share Eligible shareholders must have bought the stock before 29 December 2022. Payment date: 24 March 2023. Payout ratio is a comfortable 8.1% and the cash payout ratio is 96%. Trailing yield: 3.6%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.5%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Nov 13
Third quarter 2022 earnings released: JP¥1.62 loss per share (vs JP¥0.84 loss in 3Q 2021) Third quarter 2022 results: JP¥1.62 loss per share (further deteriorated from JP¥0.84 loss in 3Q 2021). Revenue: JP¥1.62b (up 7.2% from 3Q 2021). Net loss: JP¥23.0m (loss widened 92% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 13% per year. Announcement • Sep 28
C.E.Management Integrated Laboratory Co.Ltd to Report Q3, 2022 Results on Nov 10, 2022 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q3, 2022 results on Nov 10, 2022 Reported Earnings • Aug 12
Second quarter 2022 earnings released: EPS: JP¥3.87 (vs JP¥7.96 in 2Q 2021) Second quarter 2022 results: EPS: JP¥3.87 (down from JP¥7.96 in 2Q 2021). Revenue: JP¥1.55b (down 2.6% from 2Q 2021). Net income: JP¥55.0m (down 52% from 2Q 2021). Profit margin: 3.5% (down from 7.2% in 2Q 2021). Announcement • Jul 03
C.E.Management Integrated Laboratory Co.Ltd to Report Q2, 2022 Results on Aug 10, 2022 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q2, 2022 results on Aug 10, 2022 Upcoming Dividend • Jun 22
Upcoming dividend of JP¥5.50 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 06 September 2022. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.2%). Reported Earnings • May 16
First quarter 2022 earnings released: EPS: JP¥6.19 (vs JP¥3.77 in 1Q 2021) First quarter 2022 results: EPS: JP¥6.19 (up from JP¥3.77 in 1Q 2021). Revenue: JP¥1.74b (down 3.8% from 1Q 2021). Net income: JP¥88.0m (up 60% from 1Q 2021). Profit margin: 5.1% (up from 3.0% in 1Q 2021). Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Apr 08
C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2022 Results on May 13, 2022 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q1, 2022 results on May 13, 2022 Reported Earnings • Feb 15
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: JP¥14.86 (down from JP¥20.18 in FY 2020). Revenue: JP¥7.34b (up 18% from FY 2020). Net income: JP¥213.0m (down 27% from FY 2020). Profit margin: 2.9% (down from 4.7% in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 16% per year. Announcement • Feb 12
C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2022 C.E.Management Integrated Laboratory Co.Ltd, Annual General Meeting, Mar 23, 2022. Upcoming Dividend • Dec 22
Upcoming dividend of JP¥5.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 24 March 2022. Payout ratio is a comfortable 45% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (0.7%). Reported Earnings • Nov 13
Third quarter 2021 earnings released: JP¥0.84 loss per share (vs JP¥1.37 loss in 3Q 2020) The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: JP¥1.51b (up 10% from 3Q 2020). Net loss: JP¥12.0m (loss narrowed 40% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings. Reported Earnings • Aug 12
Second quarter 2021 earnings released: EPS JP¥7.96 (vs JP¥4.28 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥1.59b (up 5.6% from 2Q 2020). Net income: JP¥114.0m (up 84% from 2Q 2020). Profit margin: 7.2% (up from 4.1% in 2Q 2020). The increase in margin was driven by higher revenue. Upcoming Dividend • Jun 22
Upcoming dividend of JP¥4.50 per share Eligible shareholders must have bought the stock before 29 June 2021. Payment date: 07 September 2021. Trailing yield: 2.4%. Lower than top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (0.7%). Announcement • Apr 16
C.E.Management Integrated Laboratory Co.Ltd (TSE:6171) announces an Equity Buyback for 360,000 shares, representing 2.47% for ¥180 million. C.E.Management Integrated Laboratory Co.Ltd (TSE:6171) announces a share repurchase program. Under the program, the company will repurchase up to 360,000 shares, representing 2.47% of its issued share capital (excluding treasury stock), for a total purchase price of ¥180 million. The purpose of the program is to return profits to shareholders and improve capital efficiency. The program will be valid till December 23, 2021. As of March 31, 2021, the company had 14,582,995 issued shares (excluding treasury stock) and 414,700 treasury shares. Announcement • Mar 19
C.E.Management Integrated Laboratory Co.Ltd to Report Q1, 2021 Results on May 13, 2021 C.E.Management Integrated Laboratory Co.Ltd announced that they will report Q1, 2021 results on May 13, 2021 Reported Earnings • Feb 14
Full year 2020 earnings released: EPS JP¥20.18 (vs JP¥21.13 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: JP¥6.21b (up 2.3% from FY 2019). Net income: JP¥293.0m (down 3.9% from FY 2019). Profit margin: 4.7% (down from 5.0% in FY 2019). The decrease in margin was driven by higher expenses. Announcement • Jan 16
C.E.Management Integrated Laboratory Co.Ltd (TSE:6171) agreed to acquire Advanced Knowledge Laboratory Inc. from Kaoru Ikejima for ¥880 million. C.E.Management Integrated Laboratory Co.Ltd (TSE:6171) agreed to acquire Advanced Knowledge Laboratory Inc. from Kaoru Ikejima for ¥880 million on January 15, 2021. As per terms, C.E.Management Integrated Laboratory Co.Ltd shall acquire 300 shares of Advanced Knowledge Laboratory Inc. equivalent to 100% stake in Advanced Knowledge Laboratory Inc. for ¥880 million and Advisory expenses, etc. of approximate ¥57 million. For the year ending January 31, 2020, net asset, total asset, revenue, operating profit and net profit of Advanced Knowledge Laboratory Inc. was ¥340 million, ¥531 million, ¥372 million, ¥122 million and ¥80 million respectively. The transaction is expected to close on January 18, 2021. Is New 90 Day High Low • Dec 25
New 90-day low: JP¥329 The company is down 12% from its price of JP¥376 on 25 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Professional Services industry, which is up 4.0% over the same period. Is New 90 Day High Low • Dec 07
New 90-day low: JP¥357 The company is down 3.0% from its price of JP¥368 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Professional Services industry, which is up 10.0% over the same period. Announcement • Dec 05
C.E.Management Integrated Laboratory Co.Ltd to Report Fiscal Year 2020 Results on Feb 12, 2021 C.E.Management Integrated Laboratory Co.Ltd announced that they will report fiscal year 2020 results on Feb 12, 2021 
